TB-500 remains a 503A Category-2 bulk substance, while BPC-157 was removed from the 503A list in April 2026 and is under PCAC review
Rising incidence of obesity and related conditions is driving the GLP-1 industry growth
Summary Keywords GH-IGF1 signaling pathway, cancers, radiotherapy, radio-resistance, DNA damage repair Citation Cheng Y, Li W, Gui R, Wang C, Song J, Wang Z, Wang X, Shen Y, Wang Z and Hao L (2021) Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers
This may suit men highly motivated to reach full doses who can tolerate the combined titration
A smaller Italian study in the Journal of Bone and Mineral Research (2012, N=60) showed that correcting vitamin D deficiency before statin re-initiation reduced myalgia recurrence from 83% to 38% over 12 months [8]